INS and metabolic dysfunction-associated steatotic liver disease: Oxidative metabolites from arachidonic acid and linoleic acid are associated with markers of steatosis, liver injury, and insulin sensitivity, and the relevant oxidative metabolites are more abundant in the plasma of NASH patients than NAFLD patients (Civelek and Podszun, 2022; Gao et al., 2022).